Stay updated on Exemestane in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Exemestane in NSCLC Clinical Trial page.

Latest updates to the Exemestane in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe sponsor attribution was updated to 'Masonic Cancer Center, University of Minnesota' instead of 'University of Minnesota Masonic Cancer Center', aligning with the institution's preferred naming. A new page revision tag 'Revision: v3.5.4' was added to indicate the latest update.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the ClinicalTrials.gov site build rather than any modification to the study details.SummaryDifference0.1%

- Check29 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice while preserving existing trial content; no trial details are changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Exemestane in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exemestane in NSCLC Clinical Trial page.